Blood illnesses that affect red blood cells are known as hemoglobinopathies. These illnesses can be hereditary, resulting in an aberrant structure of one of the globin chains in the haemoglobin molecule.

Data Bridge Market Research analyses that the hemoglobinopathies market will exhibit a CAGR of around 10.3% for the forecast period of 2021-2028.